2010, Number 2
<< Back Next >>
TIP Rev Esp Cienc Quim Biol 2010; 13 (2)
Regulación neuroendocrinológica de la función inmunitaria: el papel de la hipófisis y los esteroides sexuales
Hernández-Cervantes R, Sánchez-Acosta AG, Ramírez-Nieto R, Morales-Montor J
Language: Spanish
References: 39
Page: 103-112
PDF size: 181.71 Kb.
ABSTRACT
The immune and neuroendocrine systems comprise a complex physiological network, in which cytokines, peptide hormones, steroid hormones and neuropeptides regulate and modify the immune response, jointly maintaining the homeostasis of the organism. Two of the main components of this network are the hypothalamus-pituitary-adrenal (HPA) and hypothalamic-pituitary-gonadal (HPG) axes. The interactions among the immune system and HPA/HPG axes are trascendental in the initiation and activation of the stress response, which in turn has immunomodulatory functions that are very important in preventing excessive immune responses. In addition, the functions of both axes affect the adaptation and maintenance of homeostasis during severe pathological processes, such as those caused by viruses, bacteria, parasites or autoimmune diseases, to name a few. An important aspect of cellular communication, which has emerged as a result of studying the neuroimmunoendocrine interactions is the redundancy in the use of a large number of chemical messengers. As an example of this redundant role, neurotrophins are mainly present in the nervous system, but are also expressed and secreted by immune and endocrine cells, ultimately regulating the function of the systems named. In this way, the loss of exclusivity in the use of chemical messengers by specific organ systems can be a rule rather than an exception. However, although a large amount of experimental evidence suggests that 1) neuronal , endocrine and immune cells produce, neurotransmitters, neurohormones, steroid and peptide hormones as well as cytokines, and although 2) all of these cell types also express receptors to all these molecules, it still remains to clarify the role of these interactions on the neuroimmunoendocrine network, particularly the one played by the pituitary gland, during health and in various diseases.
REFERENCES
Besedovsky, H.O. & Del Rey, A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr. Rev. 17(1), 64-102 (1996).
Chiodi, H. The relationship between the thymus and the sexual organs. Endocrinol. 26, 107 (1940).
Grossman, C.J., Sholiton, L.J. & Nathan, P. Rat thymic estrogen receptor. I. Preparation, location, and physiochemical properties. Steroid Biochem. 11(3), 1233-1240 (1979).
De León-Nava, M.A. & Morales-Montor, J. Dimorfismo sexual inmunitario: pueden los esteroides sexuales polarizar el perfil de citocinas Th1/Th2? Rev. Invest. Clin. 58(2), 161-169 (2006).
Tonelli, L.H. & Postolache, T.T. Tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge. Neurol. Res. 27(7), 679-684 (2005).
Agro, A. & Stanisz, A.M. Neuroimmunomodulation: classical and non-classical cellular activation. Adv. Neuroimmunol. 5(3), 311-319 (1995).
Elenkov, I.J. Glucocorticoids and the Th1/Th2 balance. Ann. N. Y. Acad. Sci. 1024, 138-146 (2004).
Daly, A.F., Burlacu, M.C., Livadariu, E. & Beckers, A. The epidemiology and management of pituitary incidentalomas. Horm. Res. 68(Suppl 5), 195-198 (2007).
Petersenn, S. et al. The Rational Use of Pituitary Stimulation Tests. Dtsch. Arztebl. Int. 107(25), 437-443 (2010).
Schneider, H.J., Aimaretti, G., Kreitschmann-Andermahr, I., Stalla, G.K. & Ghigo, E. Hypopituitarism. Lancet 369,1461-1470 (2007).
Dekkers, O.M. et al. Mortality in Patients Treated for Cushing's Disease Is Increased, Compared with Patients Treated for Nonfunctioning Pituitary Macroadenoma. J. Clin. Endocrinol. Metab. 92(3), 976-981 (2007).
Montero, A., Giovannoni, A.G. & Sen, L. Propiedades inmunológicas de la prolactina. Medicina (Buenos Aires) 60, 515-520 (2000).
Ascoli, P. & Cavagnini, F. Hypopituitarism. Pituitary 9(4), 335- 342 (2006).
Frare, E.O. et al. Growth hormones therapy in immune response against Trypanosoma cruzi. Res. Vet. Sci. 88(2), 273-278 (2009).
Nicoll, C.S. Physiological actions of Prolactin (Handbook of Physiology, Washington, D.C., 1974).
Sandoval, C., Fonseca, M.E. & Ochoa, R. The transcendence of prolactin and its relation to the immune response. Ginecol. Obstet. Mex. 65, 148-151 (1997).
Clevenger, C.V., Freier, D.O. & Kline, J.B. Prolactin receptor signal transduction in cells of the immune system. Review J. Endocrinol. 157, 187-197 (1998).
Nagy, E. & Berczi, I. Hypophysectomized rats depends on residual prolactin for survival. Endocrinology 128, 2776-2784 (1991).
Berczi, I. & Nagy, E. Immune system effects on neural and endocrine processes and behavior: Effects of hypophysectomy on immune function. In: Psychoneuroimmunology II (Ader, R., Felten, D.L. & Cohen, N. eds.) 339-375 (Academic Press, 1991).
Torner, L. et al. A 14-kilodalton prolactin-like fragment is secreted by the hypothalamo-neurohypophyseal system of the rat. Endocrinology 136(12), 5454-5460 (1995).
Mejía, S. et al. Prolactin and 16K prolactin stimulate release of vasopressin by a direct effect on hypothalamoneurohypophyseal system. Endocrine 20(1-2), 155-162 (2003).
Dzitko, K., Malicki, S. & Komorowski, J. Effect of hyperprolactinaemia on Toxoplasma gondii, prevalence in humans. Parasitol. Res. 102, 723-729 (2008).
Kodjikian, L. et al. Ocular manifestations in congenital toxoplasmosis. Graefe Arch. Clin. Exp. Ophthalmol. 244, 14- 21 (2006).
Chrousos, G.P., Kino, T. & Charmandari, E. Evaluation of the Hypothalamic-Pituitary-Adrenal Axis Function in Childhood and Adolescence. Neuroimmunomodulation 16, 272-283 (2009).
Batista, D.L., Riar, J., Keil, M. & Stratakis, C.A. Diagnostic tests for children who are referred for the investigation of Cushing syndrome. Pediatrics 120, e575-e586 (2007)
Savage, M.O. et al. Advances in the management of paediatric Cushing's disease. Horm. Res. 69, 327-333 (2008)
Tsigos, C. Differential diagnosis and management of Cushing's syndrome. Annu. Rev. Med. 47, 443-461 (1996).
Jailer, J.W. & Holub, D.A. Remission of Grave's disease following radiotherapy of a pituitary neoplasm. Am. J. Med. 28, 497-500 (1960) .
Socin, H.V. et al. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur. J. Endocrinol. 148, 433-422 (2003).
Morales-Montor, J. et al. Host gender in parasitic infections of mammals: an evaluation of the female host supremacy paradigm. J. Parasitol. 90(3), 531-546 (2004).
Grossman, C.J. Possible underlaying mechanism of sexual dimorphism in the immune response, fact and hypothesis. J. Steroid Biochem. 34(1-6), 241-251 (1989).
Bebo, B.F.Jr., Schuster, J.C., Vandenbark, A.A. & Offner, H. Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J. Immunol. 162(1), 35-40 (1999).
Da Silva, J.A. Sex hormones and glucocorticoids: interactions with the immune system. Ann. N.Y. Acad. Sci. 876, 102-118 (1999).
Olsen, N.J. & Kovacs, W.J. Effects of androgens on T and B lymphocyte development. Immunol. Res. 23(2-3), 281-288 (2001).
Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A. & Coffman, R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357 (1986).
Abbas, A.K., Murphy, K.M. & Sher, A. Functional diversity of helper T lymphocytes. Nature 38, 787-793 (1996).
Lucey, D.R., Clerici, M. & Shearer, G.M. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 9(4), 532-562 (1996).
Mosmann, T.R. & Sad, S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17, 138-146 (1996).
Mosmann, T.R. & Coffman, R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173 (1989).
Full text